Ara
Toplam kayıt 2, listelenen: 1-2
Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab
(Elsevier, 2020)
Background: In the current study, we evaluated pretreatment prognostic factors foroverall survival (OS) in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy in the Expanded-Access ...
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience
(American Society of Clinical Oncology, 2020)
...